IP6 ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 122 | 脳表ヘモジデリン沈着症 | 1 |
122. 脳表ヘモジデリン沈着症
臨床試験数 : 4 / 薬物数 : 9 - (DrugBank : 3) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04890808 (ClinicalTrials.gov) | September 2021 | 12/5/2021 | Therapeutic Antioxidant Supplementation | Therapeutic Antioxidant Supplementation for Enhancement of Neural Protection From Free-iron Toxicity in Superficial Siderosis | Superficial Siderosis | Dietary Supplement: Inosine;Dietary Supplement: IP6 | Superficial Siderosis Research Alliance Inc. | NULL | Not yet recruiting | 16 Years | 77 Years | All | 50 | N/A | NULL |